RIL
KRYS icon

Rothschild Investment LLC’s Krystal Biotech KRYS Stock Holding History

Rothschild Investment LLC’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.23K Hold
28
– – ﹤0.01% 1864
2025
Q4 		$6.9K Buy
28
+2
+8% +$421 ﹤0.01% 1729
2025
Q3 		$4.59K Sell
26
-13
-33% -$1.95K ﹤0.01% 1746
2025
Q2 		$5.36K Sell
39
-7
-15% -$1.03K ﹤0.01% 1483
2025
Q1 		$8.29K Buy
46
+29
+171% +$4.88K ﹤0.01% 1223
2024
Q4 		$2.66K Sell
17
-8
-32% -$1.42K ﹤0.01% 1632
2024
Q3 		$4.55K Buy
25
+17
+213% +$3.28K ﹤0.01% 1330
2024
Q2 		$1.47K Buy
8
+6
+300% +$1.01K ﹤0.01% 1492
2024
Q1 		$356 Buy
+2
New +$278 ﹤0.01% 1484

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rothschild Investment LLC's KRYS Position: Q1 2026 in Review

Rothschild Investment LLC held its Krystal Biotech (KRYS) position steady in Q1 2026 at 28 shares worth $7.23K. The position accounts for ﹤0.01% of the portfolio, ranked #1864.

Rothschild Investment LLC first reported a position in KRYS in Q1 2024 and has held it in 9 quarters since. The position peaked at $8.29K in Q1 2025. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Rothschild Investment LLC held 28 shares of Krystal Biotech worth $7.23K as of Q1 2026.
  • Rothschild Investment LLC left its Krystal Biotech share count unchanged in Q1 2026.
  • Krystal Biotech made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #1864 holding.
  • Rothschild Investment LLC first reported a position in Krystal Biotech in Q1 2024 and has held it in 9 quarters since.
  • Rothschild Investment LLC's Krystal Biotech position peaked at $8.29K in Q1 2025.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.